Chloroquine: Can it be a Novel Drug for COVID-19
Chloroquine: Can it be a Novel Drug for COVID-19
复制标题
DOI：
10.4103/ijabmr.ijabmr_141_20
复制
发表时间：
2020-04-01
影响因子：
1.1
通讯作者：
Mahajan, Rajiv
中科院分区：
文献类型：
--
作者：
Badyal, Dinesh Kumar;Mahajan, Rajiv
Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.
